The UK government says it will support a German biopharmaceutical company’s effort to develop vaccines to combat new variants of COVID-19, once again supporting early-stage research into products meant to control the pandemic

The UK government says it will support a German biopharmaceutical company’s effort to develop vaccines to combat new variants of COVID-19, once again supporting early-stage research into products meant to control the pandemic